A detailed history of United Services Automobile Association transactions in Amgen Inc stock. As of the latest transaction made, United Services Automobile Association holds 12,585 shares of AMGN stock, worth $3.71 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,585
Previous 15,345 17.99%
Holding current value
$3.71 Million
Previous $4.79 Million 15.42%
% of portfolio
0.1%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $853,888 - $931,168
-2,760 Reduced 17.99%
12,585 $4.06 Million
Q2 2024

Aug 06, 2024

SELL
$262.75 - $319.31 $170,787 - $207,551
-650 Reduced 4.06%
15,345 $4.79 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $25.1 Million - $30.3 Million
-93,393 Reduced 85.38%
15,995 $4.55 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $450,543 - $508,266
1,762 Added 1.64%
109,388 $31.5 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $11.5 Million - $14.2 Million
-52,411 Reduced 32.75%
107,626 $28.9 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $16,498 - $19,509
77 Added 0.05%
160,037 $35.5 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $477,771 - $582,323
-2,116 Reduced 1.31%
159,960 $38.7 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $184,598 - $234,554
-806 Reduced 0.49%
162,076 $42.6 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $5,835 - $6,581
26 Added 0.02%
162,882 $36.7 Million
Q2 2022

Aug 16, 2022

BUY
$230.71 - $256.74 $4.76 Million - $5.29 Million
20,623 Added 14.5%
162,856 $39.6 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $8.36 Million - $9.25 Million
-38,114 Reduced 21.13%
142,233 $34.4 Million
Q4 2021

Feb 16, 2022

SELL
$198.88 - $227.6 $425,603 - $487,064
-2,140 Reduced 1.17%
180,347 $40.6 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $1.23 Million - $1.44 Million
5,771 Added 3.27%
182,487 $38.8 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $11.8 Million - $13.1 Million
50,626 Added 40.15%
176,716 $43.1 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $846,586 - $986,559
3,815 Added 3.12%
126,090 $31.4 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $1.73 Million - $1.93 Million
7,393 Added 6.44%
122,275 $31.1 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $5.67 Million - $6.96 Million
-28,682 Reduced 19.98%
114,882 $27.1 Million
Q1 2020

May 14, 2020

BUY
$182.24 - $241.7 $890,242 - $1.18 Million
4,885 Added 3.52%
143,564 $29.1 Million
Q4 2019

Jan 14, 2020

SELL
$189.21 - $243.2 $544,735 - $700,172
-2,879 Reduced 2.03%
138,679 $33.4 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $111 Million - $133 Million
-636,828 Reduced 81.81%
141,558 $27.4 Million
Q2 2019

Aug 16, 2019

BUY
$166.7 - $195.41 $16.8 Million - $19.6 Million
100,540 Added 14.83%
778,386 $143 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $10.6 Million - $12 Million
58,841 Added 9.51%
677,846 $129 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $2.1 Million - $2.45 Million
11,750 Added 1.93%
619,005 $121 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $4.79 Million - $5.4 Million
-25,853 Reduced 4.08%
607,255 $126 Million
Q2 2018

Sep 27, 2018

SELL
$166.05 - $186.51 $128 Million - $143 Million
-768,205 Reduced 54.82%
633,108 $117 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $109 Million - $123 Million
658,287 Added 88.6%
1,401,313 $147 Million
Q1 2018

May 14, 2018

SELL
$169.43 - $198.0 $31.4 Million - $36.7 Million
-185,554 Reduced 19.98%
743,026 $127 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $1.67 Million - $1.86 Million
9,874 Added 1.07%
928,580 $161 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $154 Million - $175 Million
918,706
918,706 $171 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.